Amanote Research

Amanote Research

    RegisterSign In

Giant Cell Arteritis: Is the Clinical Spectrum of the Disease Changing?

BMC Geriatrics - United Kingdom
doi 10.1186/s12877-019-1225-9
Full Text
Open PDF
Abstract

Available in full text

Categories
GerontologyGeriatrics
Date

July 29, 2019

Authors
Miguel Á. González-GayMiguel Ortego-JuradoLiliana ErcoleNorberto Ortego-Centeno
Publisher

Springer Science and Business Media LLC


Related search

The Treatment of Giant Cell Arteritis in Different Clinical Settings

Frontiers in Immunology
AllergyImmunology
2019English

Giant-Cell Arteritis of the Legs

BMJ
1955English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

Clinical Study of Giant Cell Arteritis in Our Hospital

Japanese Journal of Clinical Immunology
2015English

Giant Cell Arteritis: Ophthalmic Manifestations of a Systemic Disease

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

Giant Cell Arteritis: Authors' Reply

BMJ
1992English

Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology
RheumatologyImmunology
2013English

Interstitial Lung Disease as an Initial Manifestation of Giant Cell Arteritis

Internal Medicine
Internal MedicineMedicine
2017English

Myopericarditis and Giant Cell Arteritis in the Elderly

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy